Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Merck To Shutter New Jersey Sites
by Rick Mullin
May 3, 2010
| A version of this story appeared in
Volume 88, Issue 18
Merck & Co. plans to close three sites in New Jersey as part of a consolidation following its 2009 acquisition of Schering-Plough. The company will close its Roseland and Lafayette sites this year and its Union site in 2012. Merck did not specify the number of jobs that will be eliminated, but it did say a “significant number” of personnel will relocate to other Merck facilities. The company, with headquarters in Whitehouse Station, N.J., has other New Jersey sites in Rahway, Kenilworth, and Summit. Merck says it will employ 12,000 people across these four sites.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter